Human Complement C4 Monoclonal Antibody

• Description:

  Human Complement C4 Monoclonal Antibody_x000D_ Catalog number: B2014660_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 50 ug_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Solution_x000D_ Applications: molecular tool for various biochemical applications_x000D_ Storage: −20°C_x000D_ Keywords: Human Complement C4 Monoclonal Antibody_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Patel G, Pongracic JA. Hereditary and acquired angioedema Allergy Asthma Proc. 2019 Nov 1;40(6):441-445._x000D_ 2: Röth A, Berentsen S, Barcellini W, D'Sa S, Jilma B, Michel M, Weitz IC, Yamaguchi M, Nishimura JI, Vos JMI, Storek M, Wong N, Patel P, Jiang X, Vagge DS, Wardęcki M, Shafer F, Lee M, Broome CM. Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial Blood. 2022 Sep 1;140(9):980-991._x000D_ 3: Noris M, Bresin E, Mele C, Remuzzi G. Genetic Atypical Hemolytic-Uremic Syndrome 2007 Nov 16 [updated 2021 Sep 23]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023._x000D_ 4: Rovin BH, Furie R, Latinis K, Looney RJ, Fervenza FC, Sanchez-Guerrero J, Maciuca R, Zhang D, Garg JP, Brunetta P, Appel G; LUNAR Investigator Group. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study Arthritis Rheum. 2012 Apr;64(4):1215-26._x000D_ 5: Dhillon S. Sutimlimab: First Approval Drugs. 2022 May;82(7):817-823._x000D_ 6: Chatham WW, Furie R, Saxena A, Brohawn P, Schwetje E, Abreu G, Tummala R. Long-Term Safety and Efficacy of Anifrolumab in Adults With Systemic Lupus Erythematosus: Results of a Phase II Open-Label Extension Study Arthritis Rheumatol. 2021 May;73(5):816-825._x000D_ 7: Gulati S, Beurskens FJ, de Kreuk BJ, Roza M, Zheng B, DeOliveira RB, Shaughnessy J, Nowak NA, Taylor RP, Botto M, He X, Ingalls RR, Woodruff TM, Song WC, Schuurman J, Rice PA, Ram S. Complement alone drives efficacy of a chimeric antigonococcal monoclonal antibody PLoS Biol. 2019 Jun 19;17(6):e3000323._x000D_ 8: Visentin J, Vigata M, Daburon S, Contin-Bordes C, Fremeaux-Bacchi V, Dromer C, Billes MA, Neau-Cransac M, Guidicelli G, Taupin JL. Deciphering complement interference in anti-human leukocyte antigen antibody detection with flow beads assays Transplantation. 2014 Sep 27;98(6):625-31._x000D_ 9: Dillman SL, Strelkauskas AJ, Su HR, Boackle RJ. Activation of human complement by totally human monoclonal antibodies Mol Immunol. 1995 Sep;32(13):957-64._x000D_ 10: Wolbink GJ, Bollen J, Baars JW, ten Berge RJ, Swaak AJ, Paardekooper J, Hack CE. Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway J Immunol Methods. 1993 Jul 6;163(1):67-76. _x000D_ _x000D_ Products Related to Human Complement C4 Monoclonal Antibody can be found at Antibodies

• Short Description:

  Catalog Number: B2014660 (50 ug)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5

• Height :

  0.5

• CAS Number:

  9007-83-4